![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Bets Splits in Obesity](https://a.storyblok.com/f/176343/1920x1080/0234c60f2d/home-teaser.jpg)
Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Key warnings include risk of thyroid C-cell tumors, pancreatitis, gallbladder disease, risk of acute kidney injury with severe gastrointestinal adverse reactions, and potential diabetic retinopathy complications
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Bets Splits in Obesity](https://images.wsj.net/im-47001752?width=700&height=403)
Growth hormone secretagogues (such as CJC-1295 and ipamorelin) act on the hypothalamic-pituitary axis to stimulate growth hormone release, whereas BPC-157 and TB-500 are associated with claims around tissue repair and recovery none of which are supported by robust human clinical data
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Bets Splits in Obesity](https://endpoints.news/wp-content/uploads/2020/08/Roche-social-AP-scaled.jpg)
It differs from traditional gastric bypass by using one intestinal connection
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Bets Splits in Obesity](https://cphoto.asiae.co.kr/listimglink/1/2026012819584919755_1769597929.png)
Patients exploring weight loss and metabolic support often encounter both berberine and GLP-1 medications in online discussions, leading to confusion about their roles
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity Roche Bets Splits in Obesity](https://static.biospace.com/dims4/default/7c8a734/2147483647/strip/false/crop/3803x2139+0+239/resize/1200x675!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F68%2Fb4%2Ff13d76df42619d636b92913eb589%2Fistock-804989330.jpg)
US$ 23.90
US$ 27.86
US$ 26.17
US$ 27.37
US$ 25.49
US$ 23.14
US$ 24.56
US$ 28.38
US$ 20.79
US$ 28.48
US$ 21.44
US$ 28.23
US$ 26.80
US$ 27.87
